Relapses and Deaths in 39 Patients Not Carrying a Homozygous p16 Deletion and in Nine Patients Carrying a Homozygous p16 Deletion
Parameter . | No. of Patients . | Relapse . | Death . | ||
---|---|---|---|---|---|
. | . | No. . | % . | No. . | % . |
With deletion | |||||
T-ALL | 5 | 3 | 60.0 | 2 | 40.0 |
Precursor-B-ALL | 4 | 3 | 75.0 | 3 | 75.0 |
High risk | 8 | 6 | 75.0 | 5 | 62.5 |
Standard risk | 1 | 0 | 0.0 | 0 | 0.0 |
Without deletion | |||||
T-ALL | 3 | 0 | 0.0 | 0 | 0.0 |
Precursor-B-ALL | 36 | 8* | 22.9 | 5 | 13.9 |
High risk | 15 | 4 | 26.7 | 3 | 20.0 |
Standard risk | 24 | 4† | 17.4 | 2 | 8.3 |
Parameter . | No. of Patients . | Relapse . | Death . | ||
---|---|---|---|---|---|
. | . | No. . | % . | No. . | % . |
With deletion | |||||
T-ALL | 5 | 3 | 60.0 | 2 | 40.0 |
Precursor-B-ALL | 4 | 3 | 75.0 | 3 | 75.0 |
High risk | 8 | 6 | 75.0 | 5 | 62.5 |
Standard risk | 1 | 0 | 0.0 | 0 | 0.0 |
Without deletion | |||||
T-ALL | 3 | 0 | 0.0 | 0 | 0.0 |
Precursor-B-ALL | 36 | 8* | 22.9 | 5 | 13.9 |
High risk | 15 | 4 | 26.7 | 3 | 20.0 |
Standard risk | 24 | 4† | 17.4 | 2 | 8.3 |